TYRA Stock Price
Tyra Biosciences, Inc.
TYRA stock price is $20.26 (+0.10% on the day), giving Tyra Biosciences, Inc. a market cap of $1.44B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
TYRA Stock Overview
- Price
- $20.26
- Previous close
- $20.24
- Open
- $19.97
- Market cap
- $1.44B
- P/E ratio
- -12.0
- 52-week range
- $12.98 - $40.65
- 1-year price target
- $47.45
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 33
About Tyra Biosciences, Inc.
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TYRA | $20.26 | +0.1% | 117.61K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |